Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy

Blood Adv. 2023 Apr 25;7(8):1572-1576. doi: 10.1182/bloodadvances.2022007868.
No abstract available

MeSH terms

  • B-Lymphocytes
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Lymphoma, B-Cell* / therapy
  • Lymphoma, Non-Hodgkin* / therapy